Clovis Oncology, Inc. (CLVS): Price and Financial Metrics

CLVS POWR Grades

• CLVS scores best on the Growth dimension, with a Growth rank ahead of 75.49% of US stocks.
• CLVS's strongest trending metric is Momentum; it's been moving down over the last 48 weeks.
• CLVS ranks lowest in Sentiment; there it ranks in the 0th percentile.

CLVS Stock Summary

• Clovis Oncology Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 4.42% of US listed stocks.
• CLVS's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 3.32% of US stocks.
• Clovis Oncology Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -34.61%, greater than the shareholder yield of just 8.4% of stocks in our set.
• If you're looking for stocks that are quantitatively similar to Clovis Oncology Inc, a group of peers worth examining would be ARDX, BLDP, LOGC, SILC, and FBIO.
• Visit CLVS's SEC page to see the company's official filings. To visit the company's web site, go to www.clovisoncology.com.

CLVS Valuation Summary

• CLVS's price/sales ratio is 3.6; this is 68.28% lower than that of the median Healthcare stock.
• Over the past 119 months, CLVS's price/sales ratio has gone NA NA.
• CLVS's EV/EBIT ratio has moved up 1 over the prior 119 months.

Below are key valuation metrics over time for CLVS.

CLVS Growth Metrics

• Its 3 year cash and equivalents growth rate is now at -44.05%.
• Its 2 year revenue growth rate is now at 127.58%.
• Its 2 year net income to common stockholders growth rate is now at -13.05%.

Over the past 33 months, CLVS's revenue has gone up $74,867,000.

The table below shows CLVS's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	156.944	-219.022	-310.359
2021-03-31	160.011	-232.124	-336.158
2020-12-31	164.522	-252.728	-369.212
2020-09-30	160.53	-266.822	-369.756
2020-06-30	159.361	-269.478	-385.155
2020-03-31	152.452	-307.658	-413.335

CLVS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CLVS has a Quality Grade of C, ranking ahead of 50.2% of graded US stocks.
• CLVS's asset turnover comes in at 0.271 -- ranking 164th of 677 Pharmaceutical Products stocks.
• FOLD, RDUS, and NSTG are the stocks whose asset turnover ratios are most correlated with CLVS.

The table below shows CLVS's key quality metrics over time.